Literature DB >> 34969325

A preliminary estimate of survival gain and cost-effectiveness of CAR-T in adult patients with acute lymphoblastic leukemia.

Andrea Messori1, Melania Rivano2, Daniele Mengato3, Luca Cancanelli4, Lorenzo Di Spazio5, Marco Chiumente6.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2021        PMID： 34969325     DOI： 10.1080/10428194.2021.2022141

Source DB:  PubMed          Journal:  Leuk Lymphoma        ISSN： 1026-8022


× No keyword cloud information.
  3 in total

Review 1.  The Degree of Programmed Death-Ligand 1 (PD-L1) Positivity as a Determinant of Outcomes in Metastatic Triple-Negative Breast Cancer Treated With First-Line Immune Checkpoint Inhibitors.

Authors:  Lorenzo Di Spazio; Melania Rivano; Luca Cancanelli; Marco Chiumente; Daniele Mengato; Andrea Messori
Journal:  Cureus       Date:  2022-01-09

Review 2.  Medical Therapy, Radiofrequency Ablation, or Cryoballoon Ablation as First-Line Treatment for Paroxysmal Atrial Fibrillation: Interpreting Efficacy Through the Shiny Method.

Authors:  Sabrina Trippoli; Lorenzo Di Spazio; Marco Chiumente; Andrea Messori
Journal:  Cureus       Date:  2022-02-27

3.  The "One-to-Many" Survival Analysis to Evaluate a New Treatment in Comparison With Therapeutic Alternatives Based on Reconstructed Patient Data: Enfortumab Vedotin Versus Standard of Care in Advanced or Metastatic Urothelial Carcinoma.

Authors:  Andrea Messori; Melania Rivano; Luca Cancanelli; Vera Damuzzo; Andrea Ossato; Marco Chiumente; Daniele Mengato
Journal:  Cureus       Date:  2022-08-25
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.